Navigation Links
Intrexon Organizes Around New Synthetic Biology Markets

GERMANTOWN, Md., May 9, 2013 /PRNewswire/ -- Intrexon Corporation, a leader in synthetic biology that is helping companies design and develop products incorporating its Better DNA™, today announced it has aligned its industry markets to focus on four key sectors: Health, Food, Energy and Environment.

Intrexon currently has nine collaborations in Health and Food to create products embodying engineered bio-based solutions.  The goal of the new market alignment is to accelerate business development across all of Intrexon's key market sectors using the company's Exclusive Channel Collaboration (ECC) model.

Since Intrexon's founding in 1998 the company has developed its core technology, the UltraVector® platform, to accelerate development of genetically-enhanced products at industrial scale.  Using a dynamic library of more than two million diverse, modular genetic components, UltraVector enables the discovery, design, assembly and testing of a wide spectrum of multigenic biological systems.As part of its new market strategy, Intrexon named the following executives with deep industry experience to lead each market sector:

  • Health will be led by Dr. Samuel Broder , Executive Director of the Intrexon Institute for Biomolecular Research and former Director of the National Cancer Institute.
  • Food will be led by Dr. Thomas Kasser , with more than twenty-five years of senior management experience in agricultural biotechnology and animal health and nutrition, recognized as a Monsanto Fellow for his scientific and technical excellence.
  • Energy will be led by Robert Walsh , with over 30 years of global petroleum and chemical industry experience, including 26 years at Royal Dutch Shell.
  • Environment will be led by Nick Macris , with 15 years in the specialty chemical, water treatment, agricultural chemical and biopesticide industries with many large and small companies including 3M, Rohm and Haas, and FMC Corporation
  • Chairman and Chief Executive Officer Randal J. Kirk said the new market alignment will help Intrexon achieve its vision to be one of the leading life science companies in the world.

    "Our new sector organization, led by an outstanding team of industry veterans, will bring additional focus and rapidity to solving our partners' toughest synthetic biology problems," Kirk said.  "It's a very exciting step toward empowering the bioindustrial revolution with solutions that enhance the quality and diversity of life."

    About Intrexon CorporationIntrexon Corporation is a privately held biotechnology company focused on collaborating with companies in Health, Food, Energy and the Environment to create bio-based products that improve the quality of life and the health of the planet.  Through the company's proprietary UltraVector® platform, Intrexon provides its partners with industrial-scale design and development of multigenic biology.  UltraVector delivers unprecedented control over the quality, reliability, and performance of living cells.  We call it Better DNA™ and we invite you to discover more at

    TrademarksIntrexon, UltraVector, mAbLogix and Better DNA are trademarks of Intrexon and/or its affiliates.  Other names may be trademarks of their respective owners.

    Safe Harbor StatementSome of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

    For more information regarding Intrexon Corporation, contact:Corporate Contact:Investor Contact:Marie L. Rossi, Ph.D.The Ruth GroupManager, Technical Communications

    Intrexon Corporation

    Tel: +1 301-556-9944

     Stephanie Carrington / Melanie Sollid-Penton

    Tel: +1 646-536-7017/7009 


    SOURCE Intrexon Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
    2. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
    3. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
    4. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
    5. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
    6. Physicists in Mainz and all around the world cheer the discovery of the Higgs particle
    7. BioInformatics LLC New Product Launch – RateMyProduct, a Quick Turnaround Product Assessment Tool for Life Science Suppliers
    8. Reliable electric power supply for the energy turn-around
    9. "Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals
    10. Synthetic Biology: Emerging Global Markets
    11. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
    Post Your Comments:
    (Date:12/1/2015)... ... 2015 , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas Fertility Center ... IVF lab procedures as well as continue his research efforts into the emerging technologies ... Auckland, New Zealand to bring home a High Complexity Clinical Laboratory Director named Tex,” ...
    (Date:11/30/2015)... Miami (PRWEB) , ... November 30, 2015 , ... ... Testart, M.D., will join physicians, aesthetic practitioners and aesthetics professionals from Central America ... (CIMECA), to be held in Panama City, Panama Feb. 17-19, 2016. Testart will ...
    (Date:11/30/2015)... ... November 30, 2015 , ... ... Good Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells ... operated by a world-class team of qualified medical researchers and practitioners, experienced in ...
    (Date:11/30/2015)... CHICAGO , Dec. 1, 2015  An interventional radiology ... according to the preliminary results of a study being presented ... North America (RSNA). ... been done for decades by interventional radiologists as a way ... performing the procedure as a means of treating obesity is ...
    Breaking Biology Technology:
    (Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
    (Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
    (Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
    Breaking Biology News(10 mins):